title: Effects of stable knockdown of Aurora kinase A on proliferation, migration, chromosomal instability, and expression of focal adhesion kinase and matrix metalloproteinase-2 in HEp-2 cells.
abstract: Overexpression of Aurora kinase A (AURKA) is frequently observed in various cancers, including laryngeal squamous cell carcinoma (LSCC). We investigated the effects of knockdown of AURKA on laryngeal cancer HEp-2 cells both in vitro and in vivo. A plasmid containing short hairpin (sh)RNA against AURKA was constructed and transfected into HEp-2. Measurements included the CCK-8 assay for viability and proliferation, flow cytometry for apoptosis and effects on the mitotic checkpoint, a trans-well assay for migration, immunofluorescence for assessment of genomic instability, and western blotting for protein expression. AURKA knockdown inhibited proliferation, migration, and colony formation in vitro and tumorigenicity in vivo. The knockdown induced the accumulation of cells in G2-M phase and eventual apoptosis. Knockdown of AURKA caused delayed entry into mitosis after treatment with nocodazole, reduced chromosomal instability, and decreased expression of focal adhesion kinase (FAK), phosphorylated FAK, and matrix metalloproteinase-2 (MMP-2), key regulators in cell adhesion and invasion. Knockdown of AURKA inhibits the growth and invasiveness of this LSCC cell line both in vitro and in vivo. These effects may partially result from the reduced expression of FAK and MMP-2. Knockdown of AURKA expression may represent a promising therapeutic strategy for the treatment of LSCC.
authors: Department of Otolaryngology, Head and Neck Surgery, Eye Ear Nose and Throat Hospital, Fudan University, Shanghai 200031, China.
authors: Hao
authors: H
authors: Zhang
authors: Xuehua
authors: X
authors: Chen
authors: Bingya
authors: B
authors: Liu
authors: Liang
authors: L
authors: Zhou
references: Curr Opin Investig Drugs. 2006 Dec;7(12):1044-51
references: 17209521
references: Otolaryngol Clin North Am. 2008 Aug;41(4):673-95, v
references: 18570953
references: Clin Cancer Res. 2009 Apr 1;15(7):2269-80
references: 19293255
references: Clin Cancer Res. 2006 Sep 1;12(17):5136-41
references: 16951231
references: Cell Adh Migr. 2009 Oct-Dec;3(4):347-50
references: 19690467
references: Clin Cancer Res. 2004 Nov 1;10(21):7304-10
references: 15534106
references: Neoplasia. 2009 May;11(5):418-25
references: 19412426
references: EMBO J. 1998 Jun 1;17(11):3052-65
references: 9606188
references: Expert Rev Anticancer Ther. 2009 Sep;9(9):1251-60
references: 19761429
references: PLoS One. 2010 Oct 18;5(10):e13123
references: 20976184
references: Carcinogenesis. 2007 May;28(5):1094-103
references: 17114643
references: Genes Chromosomes Cancer. 2010 Jan;49(1):9-16
references: 19787784
references: Hum Pathol. 2010 Oct;41(10):1380-6
references: 20656315
references: Cell Motil Cytoskeleton. 2003 Jun;55(2):134-46
references: 12740874
references: Clin Cancer Res. 2010 Jun 15;16(12):3171-81
references: 20423983
references: Oncogene. 1997 May 8;14(18):2195-200
references: 9174055
references: Laryngoscope. 2003 Nov;113(11):1944-8
references: 14603053
references: Cancer Biol Ther. 2009 Oct;8(19):1852-9
references: 19770595
references: Eur J Gynaecol Oncol. 2008;29(4):341-4
references: 18714566
references: Oncogene. 2006 Mar 2;25(9):1424-33
references: 16247453
references: Semin Cancer Biol. 2008 Feb;18(1):45-52
references: 17928235
references: Pediatr Blood Cancer. 2010 Jul 15;55(1):35-41
references: 20232424
references: Clin Cancer Res. 2005 Mar 1;11(5):1827-34
references: 15756006
references: Oncol Rep. 2004 Sep;12(3):593-9
references: 15289843
references: Cell Cycle. 2009 Mar 15;8(6):876-88
references: 19221504
references: Oncogene. 2003 Nov 13;22(51):8293-301
references: 14614453
references: J Pathol. 2004 Nov;204(3):326-32
references: 15372456
references: Clin Cancer Res. 2004 Mar 15;10(6):2065-71
references: 15041727
references: Nat Genet. 1998 Oct;20(2):189-93
references: 9771714
references: Genes Cells. 2002 Nov;7(11):1173-82
references: 12390251
references: Br J Cancer. 2002 Jul 15;87(2):202-7
references: 12107843
references: Prostate. 2009 Jul 1;69(10):1091-100
references: 19350549
references: Gynecol Oncol. 2011 Jan;120(1):11-7
references: 20937525
references: J Natl Cancer Inst. 2002 Sep 4;94(17):1320-9
references: 12208897
references: Nat Rev Cancer. 2005 Jan;5(1):42-50
references: 15630414
references: J Cell Sci. 2004 May 15;117(Pt 12):2523-31
references: 15128871
references: Virchows Arch. 2009 Sep;455(3):213-23
references: 19697059
references: Nat Rev Cancer. 2005 Feb;5(2):127-35
references: 15685196